Argentarii’s Edwards Lifesciences EW Stock Holding History

Argentarii’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$689K	Sell	7,977 -21	-0.3%	-$1.87K	0.21%	93
2026 Q2	$749K	Sell	7,998 -2,680	-25%	-$225K	0.23%	88
2026 Q1	$855K	Sell	10,678 -2,814	-21%	-$232K	0.3%	77
2025 Q4	$1.15M	Sell	13,492 -524	-4%	-$43K	0.37%	61
2025 Q3	$1.09M	Buy	14,016 +3,109	+29%	+$243K	0.43%	50
2025 Q2	$853K	Sell	10,907 -1,825	-14%	-$136K	0.39%	61
2025 Q1	$923K	Buy	12,732 +9,280	+269%	+$664K	0.46%	58
2024 Q4	$256K	Buy	+3,452	New	+$242K	0.13%	129

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Argentarii's EW Position: Q3 2026 in Review

Argentarii reduced its Edwards Lifesciences (EW) stake by 0.26% in Q3 2026, selling an estimated $1.87K and leaving 7,977 shares worth $689K. The position accounts for 0.21% of the portfolio, ranked #93.

Argentarii first reported a position in EW in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.15M in Q4 2025. 492 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Argentarii held 7,977 shares of Edwards Lifesciences worth $689K as of Q3 2026.
Argentarii sold 21 Edwards Lifesciences shares in Q3 2026, an estimated $1.87K.
Edwards Lifesciences made up 0.21% of Argentarii's portfolio in Q3 2026, its #93 holding.
Argentarii first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 8 quarters since.
Argentarii's Edwards Lifesciences position peaked at $1.15M in Q4 2025.
492 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Argentarii's 13F filing for Q3 2026, filed 28 Oct 2026.